Company Filing History:
Years Active: 2024-2025
Title: Francesca Algieri: Innovator in Postbiotic Research
Introduction
Francesca Algieri is a prominent inventor based in Milan, Italy. She has made significant contributions to the field of postbiotic research, focusing on innovative solutions for skin diseases and immune system modulation. With a total of 2 patents, her work is paving the way for new therapeutic approaches.
Latest Patents
Francesca's latest patents include a composition for the treatment of skin diseases, which utilizes a postbiotic-based formulation. This invention refers to a composition that includes a fermented supernatant of specific species, characterized by having DNA sequences that are essentially identical to selected sequences. The composition is designed to treat and prevent various skin and dermatological diseases related to inflammation, allergic reactions, and microbial dysbiosis, particularly affecting the epidermis.
Another notable patent focuses on a postbiotic-based composition aimed at modulating immune system activation and protecting mucosal barriers. This invention also involves a fermented supernatant, which is obtained through a fermentation process involving prebiotic fibers. The resulting composition is free from prebiotic fibers, highlighting its unique formulation.
Career Highlights
Francesca Algieri is associated with Postbiotica S.r.l., where she continues to advance her research and development efforts. Her work is characterized by a commitment to innovation and the application of scientific principles to real-world health challenges.
Collaborations
Francesca collaborates with notable colleagues, including Maria Rescigno and Giuseppe Penna. These partnerships enhance her research capabilities and contribute to the success of her projects.
Conclusion
Francesca Algieri is a trailblazer in the field of postbiotic research, with a focus on developing innovative solutions for skin health and immune system support. Her contributions are significant and continue to impact the scientific community positively.